Sabra Health Care REIT Inc (SBRA) to Issue $0.45 Quarterly Dividend
Sabra Health Care REIT Inc (NASDAQ:SBRA) declared a quarterly dividend on Thursday, August 9th, Wall Street Journal reports. Shareholders of record on Saturday, August 18th will be paid a dividend of 0.45 per share by the real estate investment trust on Friday, August 31st. This represents a $1.80 dividend on an annualized basis and a yield of 8.15%. The ex-dividend date of this dividend is Thursday, August 16th.
Sabra Health Care REIT has raised its dividend payment by an average of 4.6% annually over the last three years and has increased its dividend every year for the last 7 years. Sabra Health Care REIT has a payout ratio of 71.7% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Sabra Health Care REIT to earn $2.56 per share next year, which means the company should continue to be able to cover its $1.80 annual dividend with an expected future payout ratio of 70.3%.
Shares of NASDAQ SBRA opened at $22.08 on Friday. The company has a current ratio of 1.55, a quick ratio of 1.55 and a debt-to-equity ratio of 0.98. Sabra Health Care REIT has a one year low of $15.77 and a one year high of $23.79. The firm has a market capitalization of $3.95 billion, a price-to-earnings ratio of 9.09, a PEG ratio of 2.67 and a beta of 0.70.
Several analysts have recently issued reports on SBRA shares. Raymond James raised Sabra Health Care REIT from a “market perform” rating to an “outperform” rating in a report on Monday, May 21st. Zacks Investment Research raised Sabra Health Care REIT from a “hold” rating to a “buy” rating and set a $25.00 target price on the stock in a report on Wednesday, July 11th. Jefferies Financial Group reissued a “$21.91” rating and set a $22.00 target price on shares of Sabra Health Care REIT in a report on Wednesday, July 18th. ValuEngine lowered Sabra Health Care REIT from a “sell” rating to a “strong sell” rating in a report on Tuesday, May 22nd. Finally, Cantor Fitzgerald reissued a “buy” rating and set a $25.00 target price on shares of Sabra Health Care REIT in a report on Monday, June 4th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and five have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus target price of $22.40.
Sabra Health Care REIT Company Profile
As of March 31, 2018, Sabra's investment portfolio included 515 real estate properties held for investment (consisting of (i) 380 Skilled Nursing/Transitional Care facilities, (ii) 89 Senior Housing communities (?Senior Housing – Leased?), (iii) 24 Senior Housing communities operated by third-party property managers pursuant to property management agreements (?Senior Housing – Managed?) and (iv) 22 Specialty Hospitals and Other facilities), five assets held for sale, one investment in a direct financing lease, 21 investments in loans receivable (consisting of (i) two mortgage loans, (ii) two construction loans, (iii) one mezzanine loan, (iv) one pre-development loan and (v) 15 other loans), 13 preferred equity investments and one investment in an unconsolidated joint venture that owns 172 Senior Housing – Managed communities.
Featured Story: What is the NASDAQ Stock Market?
Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.